Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Article
Open Access

Clinical presentation and outcomes of patients with rhabdomyolysis

A tertiary care center experience

Mohammed Tawhari, Abdulaziz Aldalaan, Rahaf Alanazi, Sarah Aldharman, Turki Alnafisah, Nawaf Alawad, Abdullah M. Alhejji, Abdulrahman Yousef Alhabeeb and Moustafa S. Alhamadh
Saudi Medical Journal May 2024, 45 (5) 510-517; DOI: https://doi.org/10.15537/smj.2024.45.5.20230560
Mohammed Tawhari
From the Department of Medicine (Tawhari), King Abdulaziz Medical City, Ministry of the National Guard-Health Affairs; from the College of Medicine (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs; and from King Abdullah International Medical Research Center (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), Ministry of the National Guard-Health Affairs, Riyadh, Kingdom of Saudi Arabia.
MBBS, FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mohammed Tawhari
  • For correspondence: [email protected]
Abdulaziz Aldalaan
From the Department of Medicine (Tawhari), King Abdulaziz Medical City, Ministry of the National Guard-Health Affairs; from the College of Medicine (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs; and from King Abdullah International Medical Research Center (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), Ministry of the National Guard-Health Affairs, Riyadh, Kingdom of Saudi Arabia.
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rahaf Alanazi
From the Department of Medicine (Tawhari), King Abdulaziz Medical City, Ministry of the National Guard-Health Affairs; from the College of Medicine (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs; and from King Abdullah International Medical Research Center (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), Ministry of the National Guard-Health Affairs, Riyadh, Kingdom of Saudi Arabia.
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Aldharman
From the Department of Medicine (Tawhari), King Abdulaziz Medical City, Ministry of the National Guard-Health Affairs; from the College of Medicine (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs; and from King Abdullah International Medical Research Center (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), Ministry of the National Guard-Health Affairs, Riyadh, Kingdom of Saudi Arabia.
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Turki Alnafisah
From the Department of Medicine (Tawhari), King Abdulaziz Medical City, Ministry of the National Guard-Health Affairs; from the College of Medicine (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs; and from King Abdullah International Medical Research Center (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), Ministry of the National Guard-Health Affairs, Riyadh, Kingdom of Saudi Arabia.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nawaf Alawad
From the Department of Medicine (Tawhari), King Abdulaziz Medical City, Ministry of the National Guard-Health Affairs; from the College of Medicine (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs; and from King Abdullah International Medical Research Center (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), Ministry of the National Guard-Health Affairs, Riyadh, Kingdom of Saudi Arabia.
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdullah M. Alhejji
From the Department of Medicine (Tawhari), King Abdulaziz Medical City, Ministry of the National Guard-Health Affairs; from the College of Medicine (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs; and from King Abdullah International Medical Research Center (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), Ministry of the National Guard-Health Affairs, Riyadh, Kingdom of Saudi Arabia.
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdulrahman Yousef Alhabeeb
From the Department of Medicine (Tawhari), King Abdulaziz Medical City, Ministry of the National Guard-Health Affairs; from the College of Medicine (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs; and from King Abdullah International Medical Research Center (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), Ministry of the National Guard-Health Affairs, Riyadh, Kingdom of Saudi Arabia.
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moustafa S. Alhamadh
From the Department of Medicine (Tawhari), King Abdulaziz Medical City, Ministry of the National Guard-Health Affairs; from the College of Medicine (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), King Saud bin Abdulaziz University for Health Sciences, Ministry of the National Guard-Health Affairs; and from King Abdullah International Medical Research Center (Tawhari, Aldalaan, Alanazi, Aldharman, Alawad, Alhejji, Alhabeeb, Alhamadh), Ministry of the National Guard-Health Affairs, Riyadh, Kingdom of Saudi Arabia.
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1

    - Patients’ demographics and baseline characteristics (N=58).

    Factorsn%
    Age (years)41 (27-60.5)*
    BMI (kg/m2)26.5 (23.6-29.5)*
    Gender
    Male4984.5%
    Female915.5%
    Comorbidities
    Hypertension1627.6%
    Dyslipidemia1525.9%
    Diabetes mellitus1424.1%
    Neurological diseases712.1%
    Coronary artery disease610.3%
    Hypothyroidism610.3%
    Chronic kidney disease46.9%
    Psychiatric diseases35.2%
    Previous episode of rhabdomyolysis35.2%
    Baseline medications
    Statins1322.4%
    Recreational drugs**1220.7%
    Antipsychotics610.3%
    Anti-epileptics610.3%
    Antidepressants11.7%
    • ↵* Median (interquartile range).

    • ↵** Heroin and amphetamine. BMI: body mass index

    • View popup
    Table 2

    - Causes, complications, and outcomes of rhabdomyolysis (N=58).

    Causes of rhabdomyolysisn%
    Medication-induced2644.8%
    Statins1322.4%
    Recreational drugs915.5%
    Antipsychotics46.9%
    Strenuous exercise1729.3%
    Infection610.3%
    Trauma58.6%
    Seizure11.7%
    Post-operative11.7%
    Hypernatremia/dehydration11.7%
    Unknown11.7%
    Complications of rhabdomyolysis
    Acute kidney injury1932.8%
    ICU admission1017.2%
    Acute liver failure58.6%
    Need for dialysis35.2%
    Compartment syndrome11.7%
    Outcomes of rhabdomyolysis
    Length of hospital stay5 (3-10.3) 
    Death58.6%
    • ICU; intensive care unit

    • View popup
    Table 3

    - Patients’ vital signs and presenting signs and symptom (N=58).

    Factorsn%
    Vital signs on admission
    Systolic blood pressure125 (110-141)
    Diastolic blood pressure68.5 (61-77)
    Heart rate87.5 (73-109.3)
    Respiratory rate20 (19-23)
    Oxygen saturation97.5 (96-98)
    Clinical features of rhabdomyolysis
    Myalgia3763.8%
    Fatigue2237.9%
    Altered level of consciousness1424.1%
    Dark urine1017.2%
    Focal weakness915.5%
    Gastrointestinal manifestations712.1%
    Fever712.1%
    Dizziness58.6%
    Electrocardiograph changes2034.5%
    T Wave abnormality58.6%
    Premature ventricular complexes35.2%
    Left ventricular hypertrophy35.2%
    Sinus tachycardia35.2%
    First-degree AV block23.45%
    Prolonged Q-T23.45%
    Right bundle branch block11.7%
    Short P-R interval11.7%
    • AV: atrioventricular

    • View popup
    Table 4

    - Important longitudinal laboratory values.

    FactorsBefore AdmissionAdmissionMaximumDischarge
    CPK99 (52.5 to 157.8)6090 (1805 to 18962.8)10218 (2700.8 to 29318)692.5 (263.8 to 4908.3)
    Creatinine74 (67.3 to 107.5)102.5 (69.8 to 191.5)103.5 (70.8 to 231.3)69 (59 to 98.3)
    BUN5.2 (3.8 to 7)6.2 (3.9 to 10.9)6.5 (4.3 to 14.5)4.3 (2.8 to 6.9)
    eGFR95 (61 to 128)68 (32.8 to 116)70.5 (22.8 to 125.5)114 (71 to 146)
    Anion gap15 (13 to 17)16.5 (13.8 to 25)17.5 (15.8 to 25.5)13 (12 to 15)
    Uric acid342.5 (277 to 444)413.5 (295.5 to 598.3)413.5 (302.3 to 659.8)289 (185.5 to 393)
    Phosphorus1.2 (1.1 to 1.4)1.3 (1.1 to 1.7)1.5 (1.2 to 1.9)1.1 (1 to 1.3)
    Potassium4.2 (3.8 to 4.8)4.3 (3.9 to 4.6)4.6 (4.2 to 5.1)3.9 (3.7 to 4.3)
    Albumin41 (39 to 46.5)42.5 (38.8 to 47.3)34 (27.8 to 39.3)36.5 (32.3 to 40)
    • CPK: creatine phosphokinase, BUN: blood urea nitrogen, eGFR: estimated glomerular filtration rate

    • View popup
    Table 5

    - Comparison of the study cohort based on the development of complications (composite outcomes of death, acute kidney injury, acute liver failure, and/or multiorgan failure).

    CharacteristicsNo complicationsComplicationP-value
    n%n%
    3763.82136.2
    Age (years)37 (27-51)49 (30-67)0.086
    Body mass index (kg/m2)27 (23-28)27 (24-30)0.462
    Gender
    Male3081.1%1990.5%0.465
    Female718.9%29.5%
    Hospital stay (days)4 (3-6)6 (3-14)0.104
    The most common comorbidities
    Hypertension821.6%838.1%0.266
    Dyslipidemia821.6%733.3%0.363
    Diabetes mellitus924.3%523.8%1
    Important laboratory values at different time intervalsMedian (IQR) 
    Creatinine before admission (umol/l)71 (66-77)111 (74-125)0.008
    Creatinine on admission (umol/l)77 (68-104)217 (125-506)<0.001
    Maximum creatinine (umol/l)76 (68-104)230 (132-505)<0.001
    Creatinine on discharge (umol/l)63 (59-70)98 (69-144)0.001
    BUN before admission (mmol/l)4 (4-5)7 (5-9)0.001
    BUN on admission (mmol/l)5 (5-6)11 (9-20)<0.001
    Maximum BUN (mmol/l)5 (4-7)14 (9-21)<0.001
    BUN on discharge (mmol/l)4 (3-5)7 (5-9)0.002
    eGFR before admission (ml/min/1.73m2)107 (83-131)61 (42-95)0.008
    eGFR on admission (ml/min/1.73m2)99 (67-128)33 (14-50)<0.001
    Lowest eGFR (ml/min/1.73m2)101 (67-131)23 (12-49)<0.001
    eGFR on discharge (ml/min/1.73m2)133 (102-151)76 (46-115)0.006
    CPK on admission (IU/L)8033 (2221-20042)4878 (1607-16180)0.288
    Maximum CPK (IU/L)10440 (2830-37325)9910 (2664-25244)0.764
    CPK on discharge (IU/L)731 (302-5136)480 (230-3220)0.417
    Uric acid on admission (umol/l)362 (287-488)518 (378-1064)0.007
    Maximum uic acid (umol/l)390 (287-530)572 (378-1077)0.01
    Uric acid on discharge (umol/l)289 (187-376)305 (186-408)0.966
    Anion gap on admission (mmol/l)15 (13-18)25 (16-29)0.001
    Maximum anion gap (mmol/l)17 (15-19)25 (17-29)0.005
    Anion gap on discharge (mmol/l)14 (12-15)13 (17-29)0.197
    Albumin on admission (g/l)44 (40-46)40 (36-52)0.674
    Lowest albumin (g/l)36 (33-40)28 (23-35)0.001
    Albumin on discharge (g/l)39 (36-40)34 (30-39)0.006
    • BUN: blood urea nitrogen, eGFR: estimated glomerular filtration rate, CPK: Creatine phosphokinase

PreviousNext
Back to top

In this issue

Saudi Medical Journal: 45 (5)
Saudi Medical Journal
Vol. 45, Issue 5
1 May 2024
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical presentation and outcomes of patients with rhabdomyolysis
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
Clinical presentation and outcomes of patients with rhabdomyolysis
Mohammed Tawhari, Abdulaziz Aldalaan, Rahaf Alanazi, Sarah Aldharman, Turki Alnafisah, Nawaf Alawad, Abdullah M. Alhejji, Abdulrahman Yousef Alhabeeb, Moustafa S. Alhamadh
Saudi Medical Journal May 2024, 45 (5) 510-517; DOI: 10.15537/smj.2024.45.5.20230560

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Clinical presentation and outcomes of patients with rhabdomyolysis
Mohammed Tawhari, Abdulaziz Aldalaan, Rahaf Alanazi, Sarah Aldharman, Turki Alnafisah, Nawaf Alawad, Abdullah M. Alhejji, Abdulrahman Yousef Alhabeeb, Moustafa S. Alhamadh
Saudi Medical Journal May 2024, 45 (5) 510-517; DOI: 10.15537/smj.2024.45.5.20230560
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Exploring communication challenges with children and parents among pharmacists in Saudi Arabia
  • Exploring hypothyroidism’s effects on lipid profiles
  • Assessment of asthma control levels in a tertiary hospital
Show more Original Article

Similar Articles

Keywords

  • rhabdomyolysis
  • acute kidney injury
  • creatine phosphokinase
  • myopathy
  • muscle damage

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire